Pyelonephritis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Clinical Trials
• Forums

P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
Conditions:   Complicated Urinary Tract Infection;   Acute Pyelonephritis;   Hospital-acquired Bacterial Pneumonia;   Ventilator-associated Bacterial Pneumonia;   Complicated Intra-abdominal Infection Interventions:   Drug: co-administration of cefepime and nacubactam;   Drug: co-administration of aztreonam and nacubactam;   Drug: BAT Sponsor:   Meiji Seika Pharma Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis
Conditions:   Complicated Urinary Tract Infection;   Acute Pyelonephritis Interventions:   Drug: co-administration of cefepime and nacubactam;   Drug: co-administration of aztreonam and nacubactam;   Drug: imipenem/cilastatin Sponsor:   Meiji Seika Pharma Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials